Olleyes VisuALL Virtual Reality Visual Field Testing Shows Promise in Healthy Children
The Olleyes VisuALL could alleviate limitations in testing pediatric patients and make visual field testing more accessible, cost-effective, and convenient...
News
Canadian Nursery Big League Genetics Exporting New Strains to German Cannabis Producer DEMECAN
Agreement is DEMECAN's first to add international genetics to its collectionPHOENIX, AZ / ACCESSWIRE / April 10, 2024 / Big...
Rocket Doctor Accepted Into Google’s AI First Accelerator and Unveils Cutting-Edge AI Patient Matching and Data Summarization Technologies
LAS VEGAS, NV / ACCESSWIRE / April 10, 2024 / Rocket Doctor, a trailblazer in virtual healthcare, proudly announces at...
Aptevo Therapeutics Provides Pipeline Update
Breast cancer patient who improved from a progressive disease diagnosis to an over nine-month sustained stable disease diagnosis has now...
PharmaCord Announces Appointment of Cindy Padgett to Chief Commercial Officer
JEFFERSONVILLE, IN / ACCESSWIRE / April 10, 2024 / PharmaCord LLC, a leading provider of patient support services for the...
Yunu Adds Pediatric Oncologist Dr. Scott Bradfield as Strategic Advisor
Collaboration aims to advance pediatric oncology trial precision with the latest imaging technology.CARY, NC / ACCESSWIRE / April 10, 2024...
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
The study results revealed improvements in symptoms and quality of life in patients with musculoskeletal pain and inflammationTORONTO, April 10,...
Joint Statement Applauding Final Rule for Web Accessibility Under Title II of the ADA
WASHINGTON, April 10, 2024 (GLOBE NEWSWIRE) -- The American Council of the Blind (ACB), the American Foundation for the Blind...
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Lack of early symptom improvement is not predictive of final responder statusMALVERN, Pa., April 10, 2024 (GLOBE NEWSWIRE) -- Neuronetics,...
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder
Findings underscore the liver safety of AD04 as compared to placebo in the prior Phase 3 clinical trialGLEN ALLEN, Va.,...
BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
MISSISSAUGA, Ontario, April 10, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will...
Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that...
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
FREMONT, CA, April 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing...
Digostics and AgaMatrix Partner to Introduce Oral Glucose Tolerance Home Testing for UK Expectant Mothers
Digostics and AgaMatrix Team Up to Improve Gestational Diabetes Screening for UK Women via the Introduction of Oral Glucose Tolerance...
Cantargia Publishes Preclinical Data on the Potential of CAN10 in Systemic Sclerosis in a Leading Scientific Journal
LUND, SWEDEN / ACCESSWIRE / April 10, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm:CANTA) today reported publication of...
Eli Lilly’s and AstraZeneca’s Former Head of Research Dr. Jan Lundberg Invests in AlzeCure and is Proposed for Election to its Board
STOCKHOLM, SWEDEN / ACCESSWIRE / April 10, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB ("AlzeCure" or "the Company"), a...
Jaguar Health Reports Approval of All Proposals at April 2024 Special Meeting of Stockholders
Company not implementing a reverse split at this timeTop line results forthcoming for company's phase 3 OnTarget trial of crofelemer...
Dr. Anatoly Ripa at Smile Creators Dental Clinic with New Method of Elevating Smiles
BAY HARBOR ISLANDS, FL / ACCESSWIRE / April 8, 2024 / Dr. Anatoly Ripa, a distinguished dentist renowned for his...
CLOUD DX Signs New Contracts with 2 Ontario Community Paramedic Services
These contracts cap a record first quarter at Cloud DX, which has announced 10 new contracts and 14 contract renewals,...
AgriCann Solutions Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - April 9, 2024) - AgriCann Solutions Corp. ("AgriCann") (with its subsidiaries, collectively referred to as...